Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents

Arthritis and Rheumatism

Volumn 64, Issue 12, 2012, Pages 4125-4134

  Richter, Frank ^a   Natura, Gabriel ^a   Ebbinghaus, Matthias ^a   Von Banchet, Gisela Segond ^a   Hensellek, Susanne ^a   König, Christian ^a   Bräuer, Rolf ^a   Schaible, Hans Georg ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 6; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; JOINT SWELLING; MALE; MOUSE; NERVE CELL; NERVE EXCITABILITY; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN RECEPTOR; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SPINAL GANGLION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; ARTHRITIS, EXPERIMENTAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GANGLIA, SPINAL; HYPERALGESIA; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN-17; KNEE JOINT; MALE; MICE; MICE, INBRED C57BL; NEURONS; NOCICEPTORS; PAIN; PATCH-CLAMP TECHNIQUES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN-17;

EID: 84870323722     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37695     Document Type: Article

References (39)

1. McInnes IB, Schett G,. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-19.
2. Alber G, Kamradt T,. Regulation of protective and pathogenic Th17 responses. Curr Immunol Rev 2007; 3: 3-16. (Pubitemid 46605106)
3. Gaffen SL,. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009; 9: 556-67.
4. Pappu R, Ramirez-Carrozzi V, Ota N, Ouyang W, Hu Y,. The IL-17 family cytokines in immunity and disease. J Clin Immunol 2010; 30: 185-95.
5. Lubberts E,. IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis? Cytokine 2008; 41: 84-91.
6. Nakae S, Nambu A, Sudo K, Iwakura Y,. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171: 6173-7. (Pubitemid 37467240)
7. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010; 2: 52ra72.
8. Boettger MK, Hensellek S, Richter F, Gajda M, Stockigt R, Segond von Banchet G, et al. Antinociceptive effects of tumor necrosis factor α neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum 2008; 58: 2368-78.
9. Brenn D, Richter F, Schaible HG,. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum 2007; 56: 351-9. (Pubitemid 46106209)
10. Richter F, Natura G, Loser S, Schmidt K, Viisanen H, Schaible HG,. Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats. Arthritis Rheum 2010; 62: 3806-14.
11. Inglis JJ, Notley CA, Essex D, Wilson AW, Feldmann M, Anand P, et al. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum 2007; 56: 4015-23. (Pubitemid 350262329)
12. Hess A, Axmann R, Rech J, Finzel S, Heindl C, Kreitz S, et al. Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A 2011; 108: 3731-6.
13. Sommer C, Kress M,. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004; 361: 184-7. (Pubitemid 38609247)
14. Scholz J, Woolf CJ,. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007; 10: 1361-8. (Pubitemid 350014681)
15. Marchand F, Perretti M, McMahon SB,. Role of the immune system in chronic pain. Nat Rev Neurosci 2005; 6: 521-32. (Pubitemid 40942819)
16. Pinto LG, Cunha TM, Vieira SM, Lemos HP, Verri WA Jr, Cunha FQ, et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 2010; 148: 247-56.
17. Wan DD, Zhao YF, Wang GY, Sun B, Kong QF, Zhao K, et al. IL-17 potentiates neuronal injury induced by oxygen-glucose deprivation and affects neuronal IL-17 receptor expression. J Neuroimmunol 2009; 212: 17-25.
18. Christianson CA, Corr M, Firestein GS, Mobargha A, Yaksh TL, Svensson CI,. Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis. Pain 2010; 151: 394-403.
19. Boettger MK, Weber K, Schmidt M, Gajda M, Brauer R, Schaible HG,. Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis. Pain 2009; 145: 142-50.
20. McDougall J,. Arthritis and pain: neurogenic origin of joint pain. Arthritis Res Ther 2006; 8: 220-9.
21. Irmler IM, Gajda M, Brauer R,. Exacerbation of antigen-induced arthritis in IFN-γ-deficient mice as a result of unrestricted IL-17 response. J Immunol 2007; 179: 6228-36.
22. Pollinger B, Junt T, Metzler B, Walker UA, Tyndall A, Allard C, et al. Th17 cells, not IL-17+ γIδ T cells, drive arthritic bone destruction in mice and humans. J Immunol 2011; 186: 2602-12.
23. Iwanami K, Matsumoto I, Tanaka-Watanabe Y, Inoue A, Mihara M, Ohsugi Y, et al. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum 2008; 58: 754-63. (Pubitemid 351364873)
24. Schaible HG, Richter F, Ebersberger A, Boettger MK, Vanegas H, Natura G, et al. Joint pain. Exp Brain Res 2009; 196: 153-62.
25. Koenders MI, Marijnissen RJ, Devesa I, Lubberts E, Joosten LA, Roth J, et al. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis. Arthritis Rheum 2011; 63: 2329-39.
26. Iyoda M, Shibata T, Kawaguchi M, Hizawa N, Yamaoka T, Kokubu F, et al. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-α and IL-1β. Am J Physiol Renal Physiol 2010; 298: F779-87.
27. Shen F, Gaffen SL,. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008; 41: 92-104.
28. Van den Berg WB,. Lessons from animal models of arthritis over the past decade. Arthritis Res Ther 2009; 11: 250.
29. Baschant U, Frappart L, Rauchhaus U, Bruns L, Reichardt HM, Kamradt T, et al. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc Natl Acad Sci U S A 2011; 108: 19317-22.
30. McNamee KE, Alzabin S, Hughes JP, Anand P, Feldmann M, Williams RO, et al. IL-17 induces hyperalgesia via TNF-dependent neutrophil infiltration. Pain 2011; 152: 1838-45.
31. Segond von Banchet G, Fischer N, Uhlig B, Hensellek S, Eitner A, Schaible HG,. Molecular effects of interleukin-1β on dorsal root ganglion neurons: prevention of ligand-induced internalization of the bradykinin 2 receptor and downregulation of G protein-coupled receptor kinase 2. Mol Cell Neurosci 2011; 46: 262-71.
32. Aley KO, Martin A, McMahon T, Mok J, Levine JD, Messing RO,. Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci 2001; 21: 6933-9. (Pubitemid 32781135)
33. Gold MS, Gebhart GF,. Nociceptor sensitization in pain pathogenesis. Nat Med 2010; 16: 1248-57.
34. Jin X, Gereau RW,. Acute p38-mediated modulation of tetrodotoxin- resistant sodium channels in mouse sensory neurons by tumor necrosis factor-α. J Neurosci 2006; 26: 246-55. (Pubitemid 43089538)
35. Schaible HG, Ebersberger A, Natura G,. Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines. Arthritis Res Ther 2011; 13: R210.
36. Schuelert N, McDougall JJ,. Involvement of Nav 1.8 sodium ion channels in the transduction of mechanical pain in a rodent model of osteoarthritis. Arthritis Res Ther 2012; 14: R5.
37. Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Di Padova FE, et al. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 2005; 167: 141-9. (Pubitemid 40884777)
38. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004; 50: 650-9. (Pubitemid 38198849)
39. Kim CF, Malem-Taylor G,. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. J Pain 2011; 12: 370-83.